Brief: Aura Biosciences Q3 Operating Expenses USD 27.906 Million
13/11/2025 12:00
Nov 13 (Reuters) - Aura Biosciences Q3 operating income USD -27.906 million. Q3 net income USD -26.13 million
Recent news on Aura Biosciences
See all newsBrief: Aura Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Aura Biosciences - May Offer Securities Up To $500 Million Aggregate
Brief: Aura Biosciences Reports Second Quarter 2026 Financial Results And Recent Business Highlights
U.S. RESEARCH ROUNDUP-Aecom, Humana, Mosaic
Aura Biosciences Q1 net loss widens on higher R&D costs